- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04090983
Cognitive-Behavioral Therapy for Adults With Attention-Deficit/Hyperactivity Disorder Inattentive Presentation
March 8, 2024 updated by: Benjamin Bohman, Karolinska Institutet
Group-Based Cognitive-Behavioral Therapy for Adults With Attention-Deficit/Hyperactivity Disorder Inattentive Presentation: Randomized Controlled Trial
Using a randomized controlled design, standard treatment of group cognitive-behavioral therapy (CBT) according to the Hesslinger protocol is compared to a newly developed group treatment specifically designed for adult patients with ADHD inattentive presentation (ADHD-I) called CBT for ADHD-I (CADDI).
Research setting is psychiatric outpatient clinics.
Research hypotheses include: 1.
The CADDI protocol is more effective than standard treatment in terms of behavioral activation, procrastination, depressive symptoms, functional impairment, and quality of life, 2. Is equally effective in terms of ADHD symptoms, 3. Is more appreciated and tolerable, and 4. Outcome is mediated by mindful awareness.
Effects are followed up at 6 and 12 months post treatment.
Study Overview
Status
Active, not recruiting
Conditions
Study Type
Interventional
Enrollment (Actual)
108
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Benjamin Bohman, PhD
- Phone Number: +46 (0)72 244 49 00
- Email: benjamin.bohman@ki.se
Study Contact Backup
- Name: Elinor Eskilsson Strålin, MSc
- Phone Number: +46 (0)73 158 36 89
- Email: elinor.eskilsson.stralin@ki.se
Study Locations
-
-
Stockholm
-
Södertälje, Stockholm, Sweden, 15240
- Psychiatry Centre Södertälje
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 65 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- Principal diagnosis of ADHD inattentive presentation
- 18 years of age or older
- If on medication, it needs to be well-established since three months, and
- Prior psycho-educational intervention
Exclusion Criteria:
- Intellectual impairment
- Substance use disorder
- Difficulties in adherence to medical or other treatment
- Social and/or psychiatric problems to such an extent that they prevent focusing on treatment, or
- Simultaneous psychological treatment
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Active Comparator: Cognitive-behavioral therapy (Hesslinger protocol)
|
Cognitive-behavioral therapy in a group format focusing on improving symptoms of ADHD, specifically by using skills in counteracting hyperactivity and impulsiveness, and promoting mindful awareness.
|
Experimental: Cognitive-behavioral therapy (CADDI protocol)
|
Cognitive-behavioral therapy in a group format focusing on improving inattentive symptoms of ADHD, specifically by using skills in organizing, executing, and completing activity, and promoting mindful awareness.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Behavioral Activation for Depression Scale
Time Frame: 14 weeks
|
Total score 0-150; higher scores represent increased activation
|
14 weeks
|
Pure Procrastination Scale
Time Frame: 14 weeks
|
Total score 12-60; higher scores represent more procrastination
|
14 weeks
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Benjamin Bohman, PhD, Karolinska Institutet
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
September 1, 2019
Primary Completion (Estimated)
December 1, 2024
Study Completion (Estimated)
December 1, 2024
Study Registration Dates
First Submitted
September 13, 2019
First Submitted That Met QC Criteria
September 13, 2019
First Posted (Actual)
September 16, 2019
Study Record Updates
Last Update Posted (Actual)
March 12, 2024
Last Update Submitted That Met QC Criteria
March 8, 2024
Last Verified
March 1, 2024
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- KI-2019-02444
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on ADHD Predominantly Inattentive Type
-
Sync-Think, Inc.Sutter HealthUnknownADHD | ADHD Predominantly Inattentive Type | ADHD - Combined Type | ADHD, Predominantly Hyperactive - ImpulsiveUnited States
-
Haukeland University HospitalRecruitingADHD | ADHD Predominantly Inattentive Type | ADHD - Combined Type | ADHD, Predominantly Hyperactive - ImpulsiveNorway
-
AccareCompletedBehavioral Symptoms | Problem Behavior | ADHD | Child Behavior Problem | ADHD Predominantly Inattentive Type | ADHD - Combined Type | Behavior Problem | Disruptive Behavior | Behavioral Problem | ADHD, Predominantly Hyperactive-Impulsive TypeNetherlands
-
Sheba Medical CenterCompletedADHD Predominantly Inattentive Type | Attention Deficit/Hyperactivity Disorder Combined Type | ADHD Predominantly Hyperactivity Type | ADHD-not Other SpecifiedIsrael
-
Children's National Research InstituteRecruitingADHD | Attention Deficit Hyperactivity Disorder | Attention-Deficit Hyperactivity Disorder | Attention Deficit Disorder | ADD | ADHD Predominantly Inattentive Type | ADHD - Combined Type | ADHD, Predominantly Hyperactive - Impulsive | Attention-Deficit Disorder in Adolescence | Attention-Deficit Hyperactivity...United States
-
Alcobra Ltd.CompletedADHD, Predominantly Inattentive TypeIsrael
-
Alcobra Ltd.CompletedADHD Predominantly Inattentive TypeIsrael
-
Alcobra Ltd.CompletedADHD | Attention-Deficit/Hyperactivity Disorder, Predominantly Inattentive TypeUnited States, Israel
-
Pietro IaffaldanoCompletedADHD Predominantly Inattentive Type | Pediatric Onset Multiple Sclerosis
-
Children's Hospital Medical Center, CincinnatiNational Institute of Mental Health (NIMH)CompletedADHD - Combined Type | ADHD - Inattentive TypeUnited States
Clinical Trials on Cognitive-behavioral therapy (Hesslinger protocol)
-
Karolinska InstitutetRecruitingObsessive-Compulsive Disorder | Generalized Anxiety Disorder | Posttraumatic Stress Disorder | Social Anxiety Disorder | Panic DisorderSweden
-
Federal University of Health Science of Porto AlegreCompleted
-
National Center of Neurology and Psychiatry, JapanCompletedAnxiety Disorders | Depressive DisordersJapan
-
Eleos HealthMissouri Department of Mental HealthCompletedMood Disorders | Anxiety DisordersUnited States
-
Regionsenter for barn og unges psykiske helseThe Research Council of NorwayCompletedGeneralized Anxiety Disorder | Social Phobia | Separation Anxiety DisorderNorway
-
Claremont McKenna CollegeUniversity of California, Los AngelesCompleted
-
University of South FloridaObsessive Compulsive FoundationCompletedObsessive Compulsive Disorder | Stepped Care Cognitive Behavioral TherapyUnited States
-
University of North Carolina, Chapel HillNational Institute of Mental Health (NIMH)Completed
-
University of PittsburghWithdrawnPsychosis | Prodromal Symptoms | Prodromal Stage | Prodromal StatesUnited States